<bill session="116" type="s" number="1712" updated="2022-11-01T06:32:27Z">
  <state datetime="2019-06-04">REFERRED</state>
  <status>
    <introduced datetime="2019-06-04"/>
  </status>
  <introduced datetime="2019-06-04"/>
  <titles>
    <title type="display">Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2019</title>
    <title type="short" as="introduced">Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2019</title>
    <title type="short" as="introduced">DISARM Act of 2019</title>
    <title type="official" as="introduced">A bill to amend title XVIII of the Social Security Act to encourage the development and use of DISARM antimicrobial drugs, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="I000055"/>
  <cosponsors>
    <cosponsor bioguide_id="B001277" joined="2019-06-05"/>
    <cosponsor bioguide_id="C001070" joined="2019-06-04"/>
    <cosponsor bioguide_id="M000639" joined="2019-06-04" withdrawn="2019-06-05"/>
  </cosponsors>
  <actions>
    <action datetime="2019-06-04">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2019-06-04" state="REFERRED">
      <text>Read twice and referred to the Committee on Finance.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSFI" name="Senate Finance" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="116" type="h" number="4100" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Congressional oversight"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Government information and archives"/>
    <term name="Government studies and investigations"/>
    <term name="Infectious and parasitic diseases"/>
    <term name="Medicare"/>
  </subjects>
  <amendments/>
  <summary date="2020-08-26T15:41:40Z" status="Introduced in Senate">Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2019 or the DISARM Act of 2019

This bill requires additional payment under Medicare's inpatient prospective payment system for services that involve certain antimicrobial drugs, in accordance with specified limitations. Additionally, the Government Accountability Office must report on the barriers to developing such antimicrobial drugs and must recommend ways to address such barriers.</summary>
</bill>
